Dr. Axe Wire · Food, herbs & supplements · gut

Fenugreek Flavonoid Eases Depression Signs And Memory Loss In Stressed Mice

A fenugreek seed compound reshaped gut bacteria and eased depression-like behavior in stressed mice, published October 20, 2026.

By Dr. Axe Editorial Team · October 23, 2026 · 1 source · Watch

A flavonoid from fenugreek seeds eased depression-like behavior and memory problems in chronically stressed mice by reshaping their gut bacteria, according to a study published October 20, 2026 in Food & Function.

28-daymouse study

3doses tested

Researchers subjected male Kunming mice to chronic restraint stress, then gave them schaftoside orally at 20, 50 or 125 mg per kilogram, or the antidepressant fluoxetine at 10 mg per kilogram, daily for 28 days. Sample size was not reported. On tests measuring depression-like behavior and memory, schaftoside produced dose-dependent improvements. It reduced damage and inflammation in the hippocampus, the brain's memory center, and restored levels of three brain chemicals: serotonin, norepinephrine and acetylcholine. In the gut, it strengthened the intestinal barrier, raising tight-junction proteins and a protective mucus protein, while lowering inflammatory signals in the colon and raising the anti-inflammatory signal IL-10. Gut bacteria sequencing showed schaftoside suppressed a bacterial group tied to stress (Bacteroides) and boosted a butyrate-producing group (Butyricicoccus), a fatty acid gut bacteria make that feeds colon cells and supports barrier function.

Transplanting fecal matter from schaftoside-treated mice into antibiotic-pretreated recipient mice partly reproduced the behavioral, anti-inflammatory and gut-barrier benefits, along with similar shifts in gut bacteria and metabolites, the authors report. That result points to gut bacteria as a driver of the effect rather than a bystander. The authors also identified restored metabolism of tryptophan, an amino acid the body uses to make serotonin, and alpha-linolenic acid, an omega-3 fat, as part of the mechanism linking gut changes to brain chemistry.

28days

Male Kunming mice under chronic restraint stress were orally administered schaftoside (20, 50, and 125 mg/kg) or fluoxetine (10 mg/kg) for 28 days, after which behavioral, gut-barrier and microbiome improvements were observed

Food & Function, 2026, Dai et al.

Sample size per group was not reported, and this is animal data in male mice only, so female response and human translation remain unknown. The study tested an isolated compound at specific doses, not whole fenugreek seed or a standard food amount.

Dr. Axe’s Take

The fecal transplant result is the strongest part of this paper: moving gut bacteria from treated mice into untreated mice reproduced much of the benefit, which tells me the gut changes were driving the brain effects, not just riding along with them. I recommend fenugreek seed and a fiber-rich, fermented-food diet to support butyrate-producing bacteria, since that short-chain fatty acid keeps showing up in mood and gut-barrier research. This study tested an isolated compound at engineered doses in mice, not whole fenugreek seed in people, so I would not call it a proven antidepressant yet. Eat for gut diversity and treat real depression with a qualified provider.

— Dr. Axe

Take the Cellular Health Quiz →

Story summary

Who: Male Kunming mice under chronic restraint stress; sample size not reported
Design: Chronic stress model, oral schaftoside or fluoxetine daily for 28 days, behavioral, microbiome, metabolomic and transcriptomic analysis, plus fecal transplant confirmation
Dose: Schaftoside 20, 50 or 125 mg/kg, or fluoxetine 10 mg/kg, daily for 28 days
Primary result: Dose-dependent reduction in depression-like behavior and cognitive deficits on four behavioral tests
Secondary: Restored hippocampal serotonin, norepinephrine and acetylcholine; improved gut barrier proteins; suppressed Bacteroides, increased Butyricicoccus; fecal transplant partly reproduced effects
Funding / conflicts: Funders listed in the journal record: Natural Science Foundation of Chongqing; China Aerospace Science and Technology Corporation. Conflicts not reported in the abstract.
Date: Oct 20, 2026